Sign inGet started

Qiming U.S. Healthcare Fund II, L.P.

Insider CIK 1765710 · ELEV 10% owner · ICVX · JSPR 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
JSPR Jasper Therapeutics, Inc. P Buy2023-01-272023-04-112,666,666$1.50 $4.00M8,519,648SEC↗
ICVX Icosavax, Inc. C Conversion deriv2021-08-022021-08-0212,480,498— $00SEC↗
ICVX Icosavax, Inc. C Conversion deriv2021-08-022021-08-021,275,817— $00SEC↗
ICVX Icosavax, Inc. P Buy2021-08-022021-08-028,018$15.00 $120.3K3,518,246SEC↗
ICVX Icosavax, Inc. C Conversion2021-08-022021-08-023,310,228— $03,310,228SEC↗
ICVX Icosavax, Inc. P Buy2021-08-022021-08-02200,000$15.00 $3.00M3,510,228SEC↗
ICVX Icosavax, Inc. P Buy2021-08-022021-08-0213,333$15.00 $200.0K3,523,561SEC↗
ELEV Elevation Oncology, Inc. C Conversion deriv2021-06-292021-07-011,694,730— $00SEC↗
ELEV Elevation Oncology, Inc. C Conversion deriv2021-06-292021-07-017,000,000— $00SEC↗
ELEV Elevation Oncology, Inc. C Conversion2021-06-292021-07-01401,065— $02,057,642SEC↗
ELEV Elevation Oncology, Inc. P Buy2021-06-292021-07-01312,500$16.00 $5.00M2,370,142SEC↗
ELEV Elevation Oncology, Inc. C Conversion2021-06-292021-07-011,656,577— $01,656,577SEC↗